Penmesterol
Chemical compound
Clinical data | |
---|---|
Trade names | Pandocrine; Testopan |
Other names | RP-12222; 17α-Methyltestosterone 3-cyclopentyl enol ether |
Routes of administration | By mouth |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.000.609 |
Chemical and physical data | |
Formula | C25H38O2 |
Molar mass | 370.577 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Penmesterol (INNTooltip International Nonproprietary Name) (brand names Pandrocine, Testopan; former developmental code name RP-12222), or penmestrol, also known as 17α-methyltestosterone 3-cyclopentyl enol ether,[1] is a synthetic, orally active anabolic-androgenic steroid (AAS) that was developed in the early 1960s.[2][3][4][5] It is the 3-cyclopentyl enol ether of methyltestosterone.[6][7]
See also
References
- ^ Negwer M, Scharnow HG (4 October 2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 2653. ISBN 978-3-527-30247-5.
- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 942–. ISBN 978-1-4757-2085-3.
- ^ Azziz R (8 November 2007). Androgen Excess Disorders in Women. Springer Science & Business Media. pp. 122–. ISBN 978-1-59745-179-6.
- ^ Sittig M, William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 2935–. ISBN 978-0-8155-1856-3.
- ^ List PH, Hörhammer L (12 March 2013). Chemikalien und Drogen Teil A: N-Q. Springer-Verlag. pp. 504–. ISBN 978-3-642-65035-2.
- ^ Ercoli A, Gardi R (1960). "Δ4-3-Keto Steroidal Enol Ethers. Paradoxical Dependency of Their Effectiveness on the Administration Route". Journal of the American Chemical Society. 82 (3): 746–748. doi:10.1021/ja01488a062.
- ^ Wermuth CG (2 May 2011). The Practice of Medicinal Chemistry. Academic Press. pp. 731–. ISBN 978-0-08-056877-5.
- v
- t
- e
(incl. AASTooltip anabolic–androgenic steroid)
ARTooltip Androgen receptor antagonists | |||||
---|---|---|---|---|---|
Steroidogenesis inhibitors |
| ||||
Antigonadotropins |
| ||||
Others |
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Androgen receptor modulators
- Estrogens and antiestrogens
- Progestogens and antiprogestogens
- List of androgens/anabolic steroids
This article about a steroid is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e